James Haim I. Bicher
| James Haim I. Bicher | |
|---|---|
 Dr. James Bicher at his desk | |
| Born |
May 12, 1937 San Cristóbal, Santa Fe, Argentina |
|
Medical career | |
| Profession | Radiation Oncologist |
James Haim I. Bicher, M.D. (born May 12, 1937 in San Cristóbal, Santa Fe, Argentina) is an American radiation oncologist. He is a pioneer in the clinical use of Hyperthermia combined with low dose (protracted) radiation therapy (thermoradiotherapy). He is a founder and past president of ISOTT,[1] North American Hyperthermia Group, and the American Society of Clinical Hyperthermic Oncology. Dr. Bicher was a student of Nobel Prize winner Bernardo Alberto Houssay, and one of the pioneer contributors[2] to the basic principles that allowed later development of Plavix.
Dr. Bicher is the founder and a director of Bicher Cancer Institute. Prior to this role his career included the following positions: Chief of Hyperthermic Clinic at Western Tumor Medical Group in Van Nuys, California, Director of NonIonizing Radiation Cancer Treatment Center at Henry Ford Hospital in Detroit, Michigan, and Associate Chief of Department of Radiation Medicine at Roswell Park Cancer Institute in Buffalo, New York.
He currently serves as the North American Vice-President of the International Clinical Hyperthermia Society[3] and Senior Consultant at the Beritashvili Institute of Physiology, Georgian Academy of Sciences, Georgia.
References
- ↑ Bruley, Duane Frederick (2008). "ISOTT: Roots, Founding and Beyond (Oxygen Transport to Tissue XXIX)". Advances In Experimental Medicine And Biology. 614: 1–8. doi:10.1007/978-0-387-74911-2_1. ISBN 978-0-387-74910-5. PMID 18290308.
- ↑ Bicher, Haim (1972). Blood Cell Aggregation in Thrombotic Processes. Springfield: Charles C. Thomas. ISBN 9780398022327.
- ↑ ICHS Officers, International Clinical Hyperthermia Society